Skip to main content

Table 1 Studies of the effects of Volatile Anesthetic Pretreatment relating to Akt, ROS, and ERK Mechanisms in cardioprotection

From: The role of Volatile Anesthetics in Cardioprotection: a systematic review

Model

Anesthetic

Interventions

Mechanism

Length of ischemia

Infarct size

Ref #

Isolated, perfused rat hearts with IR injury

Sevoflurane

Compound C, MPG

AMPK, eNOS

35 min

/

[24]

Isolated human right atrial trabeculae with IR injury

Sevoflurane & desflurane

MPG

ROS

30 min

/

[26]

Isolated rat ventricular cardiomyocytes with oxidative stress

Desflurane & sevoflurane

MPG

ROS

/

/

[31]

Global rabbit cardiac IR injury

Isoflurane

Wortmannin & LY204002

Akt & Bcl-2

40 min

41% control

[32]

     

22% APT

 

Isolated rat ventricular myocytes with hypoxia, hydrogen peroxide or neutrophil exposure

Isoflurane

H2O2 or neutrophils

Akt & Bcl-2

/

/

[33]

Inner mitochondrial membranes from isolated human left ventricles

Isoflurane

H2O2, ATP

ROS & KATP channel

/

/

[34]

Isolated right ventricular rat trabeculae with IR injury

Sevoflurane

KB-R7943 or SEA0400

PKC, Na+/Ca2+ channel

40 min

/

[35]

Isolated guinea pig hearts with IR injury

Sevoflurane

Superoxide dismutase, catalase & glutathione

ROS

30 min

49% control

[36]

     

25% APT

 

Isolated guinea pig ventricular myocytes

Isoflurane

N-acetyl cysteine, carnosine, superoxide dismutase, & catalase

ROS, sarcolemmal KATP channel

/

/

[37]

Isolated rat ventricular myocytes with IR injury

Isoflurane

MPG

Ca2+, ROS

30 min

/

[38]

Isolated guinea pig hearts with IR injury

Sevoflurane

Chelerythine, PP101, PP149

ROS, PKC

30 min

/

[39]

Isolated rat trabeculae with IR injury

Sevoflurane

Chelerythine, 5-HD, MPG

ROS, mPTP, PKC

30 min

/

[40]

Isolated rat trabeculae with IR injury

Sevoflurane

L-tyrosine, superoxide dismutase, glutathione, catalase, & L-NAME

ROS & NOS

30 min

50% control

[41]0

     

18% APT

 

Regional rat cardiac IR injury

Desflurane

Calphostin C, PD98059

PKC, ERK1/2

25 min

57% control

[42]

     

35% APT

 
  1. Please note that “/” indicates that either this information was not printed or did not apply to the study. Ischemia-reperfusion (IR); Anesthetic Pretreatment (APT); Wortmannin & LY204002, PI3K inhibitors; hydrogen peroxide (H2O2); MPG, ROS scavenger; reactive oxygen species (ROS); Compound C, AMPK inhibitor; endothelial nitric oxide synthase (eNOS); KB-R7943 & SEA0400, Na+/Ca2+ channel inhibitors; N-acetyl cysteine, carnosine, superoxide dismutase & catalase (radical scavengers); PP101, PKC-δ inhibitor; chelerythrine (PP149), PKC-ϵ inhibitor; 5-HD, KATP channel blocker; mitochondrial permeability transition pore (mPTP); L-NAME, NOS inhibitor; calphostin C, PKC blocker; PD98059, ERK1/2 inhibitor.